Isoket Dosing for a 39 kg Child
There is no established pediatric dosing for isosorbide dinitrate (Isoket) in children, and the available evidence does not support its routine use in this population. The provided guidelines and drug labeling do not include pediatric dosing recommendations for Isoket, and you should consult a pediatric cardiologist or intensivist before administering this medication to a child.
Key Evidence Gaps
The 2008 American Academy of Pediatrics guideline on pediatric emergency drugs 1 does not include isosorbide dinitrate in its comprehensive list of emergency medications for children. This notable absence suggests it is not a standard pediatric medication.
The FDA drug label for Isoket 2 only provides dosing for:
- Adults and children ≥12 years: 10 drops up to 3 times daily (sublingual)
- Children <12 years: "Consult a physician" - no specific dose provided
Limited Pediatric Research
One small study from 1991 3 evaluated intracoronary ISDN in 8 children with normal coronary arteries using 100 mcg/kg as a single intracoronary injection. However, this was:
- An investigational study, not clinical practice
- Intracoronary route (not IV or oral)
- In children with normal coronaries (not heart failure or other conditions)
- Not intended for therapeutic dosing guidance
Clinical Approach
For a 39 kg child requiring nitrate therapy:
- Reconsider the indication - Nitrates are rarely first-line in pediatric cardiac conditions
- Consider alternatives - Other vasodilators may have better pediatric evidence
- If ISDN is truly necessary, obtain specialist consultation (pediatric cardiology/critical care) before dosing
- If emergent use is required and specialist unavailable, the intracoronary study dose of 100 mcg/kg 3 could theoretically translate to 3.9 mg for this 39 kg child, but this extrapolation is not validated for clinical use
Critical Caveats
- Nitrate tolerance develops rapidly with continuous use, limiting effectiveness
- Hypotension risk is significant, especially in volume-depleted children
- No mortality/morbidity data exists for ISDN in pediatric populations
- The homeopathic formulation referenced 2 appears unrelated to standard isosorbide dinitrate therapy
Bottom line: Do not dose Isoket in this child without specialist guidance, as pediatric safety and efficacy are not established.